Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Justin Morgan

Physician Assistant Morgantown, WV Physician Assistant

NPI 1437389293 CMS profile 10642270

6000 Memorial Church Drive, Morgantown, WV 26501

Open in the dashboard

General payments

$4,728

273 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Justin Morgan of Morgantown, WV is reported in the CMS Open Payments database as having received $4,728 across 273 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $715 37
2024 General $1,048 63
2023 General $996 56
2022 General $1,112 70
2021 General $856 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justin Morgan
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Justin Morgan were reported at $715. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Justin Morgan Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $856 $132 $37–$438 $132
2022 $1,112 $155 $48–$522 $149
2023 $996 $167 $52–$557 $160
2024 $1,048 $178 $55–$600 $164
2025 $715 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,103 69 payments
  2. Novo Nordisk Inc $789 38 payments
  3. AstraZeneca Pharmaceuticals LP $385 22 payments
  4. Pfizer Inc. $359 20 payments
  5. Bayer HealthCare Pharmaceuticals Inc. $229 13 payments
  6. Astellas Pharma US Inc $193 10 payments
  7. Lilly USA, LLC $176 12 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $144 8 payments
  9. Salix Pharmaceuticals, a division of Bausch Health US, LLC $136 7 payments
  10. Novartis Pharmaceuticals Corporation $132 8 payments
  11. Other $1,082 66 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,728 273 payments
Products named General payments · program years 2021–2025
  1. Ozempic $602 28 payments
  2. RYBELSUS $582 27 payments
  3. UBRELVY $489 23 payments
  4. LINZESS $386 30 payments
  5. Kerendia $229 13 payments
  6. QULIPTA $216 11 payments
  7. NURTEC ODT $197 10 payments
  8. FARXIGA $192 9 payments
  9. Wegovy $187 10 payments
  10. Veozah $159 8 payments
  11. Other $3,356 206 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 22 drugs

Part D claims

647

Median for Physician Assistant: 241

Drug cost

$5,863

Median for Physician Assistant: $4,110

Branded share of claims

24.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cefuroxime Cefuroxime Axetil Brand 57 $1,218
Methylprednisolone Generic 131 $804
Albuterol Sulfate Hfa Albuterol Sulfate Brand 28 $684
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 54 $476
Azelastine Hcl Generic 11 $379
Fluticasone Propionate Generic 26 $324
Gabapentin Generic 20 $320
Doxycycline Hyclate Generic 35 $279
Cefdinir Generic 12 $238
Nystatin Generic 13 $181

The 10 drugs with the highest cost, of 22 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$18,843

Of which drugs: $1,233

Medicare patients

231

Average age 74

Services billed

1,089

126 women, 105 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Ischemic heart disease 33%
Diabetes 26%
Atrial fibrillation 23%
Depression 21%
Heart failure 18%
Chronic kidney disease 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Vaccine for influenza for injection into muscle 90662 Office 14 14 $1,145

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 28 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
UBRELVY
  • AbbVie, Inc. $83
$83 — —
Veozah
  • Astellas Pharma US Inc $80
$80 — —
LINZESS
  • AbbVie, Inc. $72
$72 — —
Wegovy
  • Novo Nordisk Inc $67
$67 — —
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $65
$65 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 28 with Patron

Records

273 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record